Repligen | RGEN - 营业利润

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.35B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	营业利润	更改		日
Agilent	USD 353M		90M	2025-12
Align Technology	USD 224.71M		40.06M	2025-12
Bio Techne	USD 54.46M		6.8M	2025-12
BioMarin Pharmaceutical	USD 198.39M		230.08M	2025-12
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Bruker	USD 76.3M		7.6M	2025-12
Charles River Laboratories	USD 75.82M		57.98M	2025-12
Danaher	USD 1.5B		348M	2025-12
Dentsply International	USD 538M		26M	2025-12
Exact Sciences	USD -25M		22.85M	2025-09
General Electric Aerospace	USD 1.77B		536M	2025-12
Henry Schein	USD 186M		12M	2025-12
Illumina	USD 256M		6M	2025-12
IQVIA Holdings	USD 2.68B		2.1B	2025-12
Mettler Toledo International	USD 351.93M		57.73M	2025-12
Myriad Genetics	USD -3M		20.3M	2025-12
OraSure Technologies	USD -13.59M		2.13M	2025-12
Pacific Biosciences Of California	USD -53.19M		35.08M	2025-12
Pfizer	USD 4.65B		3.99B	2025-12
Repligen	USD 19.97M		7.29M	2025-12
Revvity	USD 145.83M		47.49M	2025-12
Standard Biotools	USD -21.92M		1.55M	2025-12
Thermo Fisher Scientific	USD 2.3B		226M	2025-12
Waters	USD 270.52M		78.4M	2025-12
West Pharmaceutical Services	USD 162.5M		5.1M	2025-12